Floatz logo

Clofarabine

Central Nervous System Leukemia

National Cancer Institute (NCI)Small moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Central Nervous System Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Masonic Cancer Center, University of Minnesota
Phase 3BB
ETOPOSIDE
National Cancer Institute (NCI)
Phase 3BB
Inno-206
Children's Oncology Group
Phase 3BB
THIOGUANINE ANHYDROUS
Children's Oncology Group
Phase 3BB
METHOTREXATE
Children's Oncology Group
Phase 3BB

View all 24 →

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BB
Indicative ·
70 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →